Jonathan Richard Weinstein

Jonathan Weinstein practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Jonathan Weinstein's NPI, 1437235256, was assigned on October 27, 2006. Jonathan Weinstein graduated from University of California, Irvine, California College of Medicine in 1998. Jonathan Weinstein holds Washington license MD00041581.

Jonathan Weinstein's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Jonathan Weinstein's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. Jonathan Weinstein is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Jonathan Weinstein to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jonathan Weinstein practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Jonathan Weinstein's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Jonathan Weinstein is licensed in Washington.

CMS data shows 136 Medicare services from Jonathan Weinstein across 6 procedure codes in 2024, for 86 Medicare patients. Medicare paid $10,374 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 86 Medicare patients who saw Jonathan Weinstein in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jonathan Weinstein's median patient age at 65, with 53% women.

In 2024, Jonathan Weinstein wrote 30 Medicare Part D claims for 11 patients. 97% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $126 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Jonathan Weinstein for performance year 2024, reported through an alternative payment model (APM). Jonathan Weinstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jonathan Weinstein as offering telehealth.

Dmand AI links 30 papers to Jonathan Weinstein, published from 2008 to 2024. 2012 was the busiest year, with 3. The most frequent topics are Microglia, Stroke and Brain Ischemia. Jonathan Weinstein has published most often in Glia. Jonathan Weinstein's most frequent co-authors are Kyra J. Becker, Dean Kazuo Shibata, MD and Claire J. Creutzfeldt, MD.

CMS Open Payments shows 1 general payment to Jonathan Weinstein from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $14.

Jonathan Weinstein graduated from University of California, Irvine, California College of Medicine in 1998.